RNS No 3761p
THERAPEUTIC ANTIBODIES INC
13 September 1999


Therapeutic Antibodies Inc ("Therapeutic Antibodies" or the "Company")

Result of the Annual Meeting of Stockholders (the "Annual Meeting")

The Board of Therapeutic Antibodies announces that at the Annual Meeting held
earlier today, all resolutions, including the resolution to approve the
proposed merger with Proteus International plc ("Proteus"), (the "Merger"),
were duly passed.

It is expected that completion of the Merger will occur at 9 am on 15
September 1999, when it is expected that dealings in the new Protherics PLC
Ordinary Shares will commence. Also at that time it is expected that the
cancellation of the listing of Therapeutic Antibodies' common stock on the
London Stock Exchange will become effective.

Enquiries:

Therapeutic Antibodies Inc
Dr. Andrew Heath           Tel: 001 615 963 4511



END

RAGSFAFIDUUUFLU
Becket Invest (LSE:TAB)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Becket Invest.
Becket Invest (LSE:TAB)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Becket Invest.